| |
The viewpoints and needs of consumers and prescribers is of the utmost importance when determining the viability of any undertaking in the pharmaceutical space. With this in mind, Frost & Sullivan embarks on a mission to address issues regarding drug delivery technologies in the U.S. pharmaceutical market with the commencement of the below feasibility survey.
Click here to participate in Frost & Sullivan’s
U.S. Drug Delivery: Voice of the Customer 2012 Feasibility Survey
Frost & Sullivan has conducted this highly successful Voice of Customer multi-client project in the drug delivery area over the past several years. The company is currently seeking partner organizations for new research on preferences, drivers of adoption, and other critical dynamics for various drug delivery technologies in the pharmaceutical market. The focus is on evaluating interest for a project concentrated on a key therapeutic area for an in-depth look at these issues from the end-users’ perspective.
If you are interested in more information, or the opportunity to sponsor or shape research for the U.S. Drug Delivery: Voice of the Customer 2012 Feasibility Survey, please contact Britni Myers, Corporate Communications, at britni.myers[.]frost.com, with your full name, company name, job title, telephone number, company email address, company Website, city, state and country. Based on your area of interest, respondents will have the opportunity to share insight with the research team as well as receive subsequent research findings information.
“Developers can gain critical insights by holistically looking at issues regarding drug delivery and treatment, including compliance, preferences, future desires, unmet needs, brand assessments, and other aspects of care delivery,” said Frost & Sullivan Research Director Daniel Ruppar. “This intelligence can prove vital in product development as well as portfolio and lifecycle management decisions.”
Earlier, highly advantageous Voice of Customer quantitative projects included hundreds of interviews with past survey groups, comprised of primary care physicians, specialists (as relevant for topic areas), nurses, patients, as well as Tier 1 and 2 companies involved in the drug delivery space. Using this broad range allows analysts to capture an overview of varied experience bases and expectations from both providers and patients on the targeted topic area over a prolonged period.
“Both providers and patients have different views, needs and objectives regarding drug treatment,” said Ruppar. “By assessing multiple stakeholder groups, companies can gain a 360-degree perspective.”
U.S. Drug Delivery: Voice of the Customer 2012 Feasibility Survey is part of ongoing research conducted within the global Life Sciences Growth Partnership Services program, which includes a focus on the pharmaceutical, biotechnology, life science research tools, and in-vitro diagnostics markets. Recent Life Sciences research includes: Specialty Physicians Discuss their Opinions of the United States Biosimilars Market, Analysis of the European Multiple Sclerosis Market, Strategic Analysis of the U.S. Next-Generation Sequencing Services Market, Analysis of the United Sates Glaucoma Pharmaceuticals Market, and Global Protein Purification Reagents Market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.
U.S. Drug Delivery: Voice of the Customer 2012 Feasibility Survey
|
britni.myers[.]frost.com 
